The Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial is a single center, double-blind, randomized, active-comparator controlled clinical trial to assess the analgesic efficacy of intercostal nerve block by Liposomal Bupivacaine versus Standard Bupivacaine in subjects undergoing lung resection by robotic or video-assisted thoracoscopic surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
91
5cc of drug preparation will be percutaneously injected into each intercostal space 3-10 under direct intrathoracic vision and subcutaneously into each surgical wound at the conclusion of the surgery.
5cc of drug preparation will be percutaneously injected into each intercostal space 3-10 under direct intrathoracic vision and subcutaneously into each surgical wound at the conclusion of the surgery.
University of California, San Francisco
San Francisco, California, United States
Average Daily In-Hospital Use of Opioids
Measured in Oral Morphine Equivalents per Day
Time frame: Average over Entire Length of Hospitalization (Up to 1 Week)
Average Daily In-Hospital Pain Score
Measured 0-10 Visual Analog Scale for Pain (Higher Score Means Worse Pain).
Time frame: Average over Length of Hospitalization - Up to 1 Week
Number of Participants With Postoperative Pneumonia
Pneumonia (Y/N)
Time frame: Index Hospitalization following Surgery until Discharge - Up to 1 Week
Length of Stay
Measured in Days
Time frame: Index Hospitalization following Surgery until Discharge - Up to 1 Week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.